Gender differences in adiponectin and low-grade inflammation among individuals with normal glucose tolerance, prediabetes, and type 2 diabetes

Gender Medicine

Volumn 6, Issue 3, 2009, Pages 463-470

  Saltevo, Juha ^a   Kautiainen, Hannu ^a,b   Vanhala, Mauno ^a,c  

^a Central Finland Central Hospital   (Finland)

^b Orton Hospital   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

adiponectin; hs CRP; IL 1RA; low grade inflammation; prediabetes; type 2 diabetes

Indexed keywords

ADIPONECTIN; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FINLAND; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; AGED; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MIDDLE AGED; PREDIABETIC STATE; SEX FACTORS;

EID: 70350072246     PISSN: 15508579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genm.2009.09.006     Document Type: Article

References (33)

1. Almdal T., Scharling H., Jensen J.S., and Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: A population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med. 164 (2004) 1422-1426
2. de Vegt F., Dekker J.M., Jager A., et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA. 285 (2001) 2109-2113
3. The DECODE Study Group and the European Diabetes Epidemiology Group. Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria. Lancet. 354 (1999) 617-621
4. Juutilainen A., Kortelainen S., Lehto S., et al. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care. 27 (2004) 2898-2904
5. Barrett-Connor E.L., Cohn B.A., Wingard D.L., and Edelstein S.L. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study [published correction appears in JAMA. 1991;265:3249]. JAMA. 265 (1991) 627-631
6. Weyer C., Funahashi T., Tanaka S., et al. Hypo-adiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 86 (2001) 1930-1935
7. Rathmann W., Haastert B., Herder C., et al. Differential association of adiponectin with cardiovascular risk markers in men and women?. The KORA survey 2000. Int J Obes (Lond). 31 (2007) 770-776
8. Snijder M.B., Heine R.J., Seidell J.C., et al. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: The Hoorn Study. Diabetes Care. 29 (2006) 2498-2503
9. Pickup J.C., and Crook M.A. Is type II diabetes mellitus a disease of the innate immune system?. Diabetologia. 41 (1998) 1241-1248
10. Pradhan A.D., Manson J.E., Rifai N., et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 286 (2001) 327-334
11. Snijder M.B., Dekker J.M., Visser M., et al. Prospective relation of C-reactive protein with type 2 diabetes: Response to Han et al. Diabetes Care. 26 (2003) 1656-1657 author reply
12. Snijder M.B., Dekker J.M., Visser M., et al. Prospective relation of C-reactive protein with type 2 diabetes: Response to Han et al. Diabetes Care. 26 (2003) 1657-1658
13. Doi Y., Kiyohara Y., Kubo M., et al. Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: The Hisayama Study. Diabetes Care. 28 (2005) 2497-2500
14. Han T.S., Sattar N., Williams K., et al. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care. 25 (2002) 2016-2021
15. Thorand B., Baumert J., Kolb H., et al. Sex differences in the prediction of type 2 diabetes by inflammatory markers: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Diabetes Care. 30 (2007) 854-860
16. Ruotsalainen E., Salmenniemi U., Vauhkonen I., et al. Changes in inflammatory cytokines are related to impaired glucose tolerance in offspring of type 2 diabetic subjects. Diabetes Care. 29 (2006) 2714-2720
17. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. Report no: WHO/NCD/NCS/99.2. (1999), World Health Organization, Geneva, Switzerland. http://www.staff.ncl.ac.uk/philip.home/who_dmg.pdf Accessed August 22, 2009
18. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 31 Suppl 1 (2008) S55-S60
19. Westerbacka J., Corner A., Tiikkainen M., et al. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: Implications for sex differences in markers of cardiovascular risk. Diabetologia. 47 (2004) 1360-1369
20. Thorand B., Baumert J., Döring A., et al., the KORA Group. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis. 184 (2006) 216-224
21. Laughlin G.A., Barrett-Connor E., and May S. Sex-specific determinants of serum adiponectin in older adults: The role of endogenous sex hormones. Int J Obes (Lond). 31 (2007) 457-465
22. Shields B.M., Knight B., Hopper H., et al. Measurement of cord insulin and insulin-related peptides suggests that girls are more insulin resistant than boys at birth. Diabetes Care. 30 (2007) 2661-2666
23. Schwartz P.E., Towers G.W., Fischer S., et al. Hypo-adiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoter. Diabetes Care. 29 (2006) 1645-1650
24. Haffner S.M., Miettinen H., and Stern M.P. Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men. Diabetologia. 40 (1997) 711-717
25. Yang W.S., Lee W.J., Funahashi T., et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin [published correction appears in J Clin Endocrinol Metab. 2002;87:1626]. J Clin Endocrinol Metab. 86 (2001) 3815-3819
26. Madsen E.L., Rissanen A., Bruun J.M., et al. Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: A 3-year weight loss study. Eur J Endocrinol. 158 (2008) 179-187
27. Ahonen T.M., Kautiainen H.J., Keinänen-Kiukaanniemi S.M., et al. Gender difference among smoking, adiponectin, and high-sensitivity C-reactive protein. Am J Prev Med. 35 (2008) 598-601
28. Blüher M., Williams C.J., Klöting N., et al. Gene expression of adiponectin receptors in human visceral and subcutaneous adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical training. Diabetes Care. 30 (2007) 3110-3115
29. Montecucco F., and Mach F. Update on therapeutic strategies to increase adiponectin function and secretion in metabolic syndrome. Diabetes Obes Metab. 11 (2009) 445-454
30. Ong K.K., Frystyk J., Flyvbjerg A., et al. Sex-discordant associations with adiponectin levels and lipid profiles in children. Diabetes. 55 (2006) 1337-1341
31. Devaraj S., Torok N., Dasu M.R., et al. Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: Evidence for an adipose tissue-vascular loop. Arterioscler Thromb Vasc Biol. 28 (2008) 1368-1374
32. Kim J.Y., van de Wall E., Laplante M., et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest. 117 (2007) 2621-2637
33. Shand B., Elder P., Scott R., et al. Biovariability of plasma adiponectin. Clin Chem Lab Med. 44 (2006) 1264-1268